Skip to main content

Aghazadeh Behzad

In the past year, 1 open-market purchase filing worth $36.3M and no sales.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
$36.3M
1 filing
Sold
–
0 filings
Net
+$36.3M
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Aghazadeh Behzad as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

SCTX Scribe Therapeutics, Inc.

Director, 10% Owner, Other: See Remarks1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 28, 2026 (view filing)9:30 PM ETJul 24-284 daysAvoro Capital Advisors LLC and 2 othersDirector, 10% Owner, Other: See RemarksPPurchaseCommon Stock, par value $0.0001 per share+2.39M$15.16+$36.3M+342.8%3.09M after3 lots

CBAY CymaBay Therapeutics, Inc.

10% Owner4 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2023 (view filing)12:53 PM ETSep 12-132 daysAvoro Capital Advisors LLC and 1 other10% OwnerSSale−300.0K$0.0103−$3.09K–950 afterDerivative4 lots
Sep 14, 2023 (view filing)12:53 PM ETSep 122 daysAvoro Capital Advisors LLC and 1 other10% OwnerPPurchase+583.8K$17.13+$10.0M–583.8K afterDerivative
Jan 30, 2023 (view filing)4:30 PM ETJan 264 daysAvoro Capital Advisors LLC and 1 other10% OwnerPPurchase+2.14M$7.00+$15.0M–2.14M afterDerivative
Nov 23, 2021 (view filing)4:15 PM ETNov 221 dayAvoro Capital Advisors LLC and 1 other10% OwnerPPurchase+2.50M$4.00+$10.0M–2.50M afterDerivative